#Point-of-Care Coagulation Testing Market Size
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
When “GIF” was named word of the year in 2012, Oxford Dictionaries U.S.A. credited Tumblr for pushing the word.
Text
Africa IVD Market - Opportunity Analysis and Industry Forecast (2024-2031)
Meticulous Research®, a premier global market research firm, has released its latest report titled, “Africa IVD Market Size, Share, Forecast & Trends Analysis by Offering, Technology (Immunoassay, PoC, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoCT), End User - Forecast to 2031.”
The report projects that the Africa in vitro diagnostics (IVD) market will reach $1.65 billion by 2031, growing at a CAGR of 3.1% from 2024 to 2031. This growth is driven by several factors, including:
Increasing prevalence of chronic and infectious diseases.
Significant investments from IVD market players in Africa.
Rising demand for Point-of-Care (POC) and rapid diagnostic solutions.
Growing geriatric population.
Government initiatives enhancing healthcare infrastructure.
Increased healthcare expenditure and R&D investments.
Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5415
Despite these opportunities, the market faces challenges such as high costs associated with advanced IVD products, variability in rapid test results, and stringent regulatory requirements for high and moderate-complexity tests.
Emerging Opportunities
The report highlights the growing awareness of early diagnosis, advancements in genomics and proteomics, and the rising adoption of personalized medicine as potential growth drivers for market stakeholders. However, uneven healthcare access and a shortage of trained professionals remain significant hurdles.
Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/africa-ivd-market-5415
Key Players in the Africa IVD Market
Leading companies in the Africa IVD market include:
Abbott Laboratories (U.S.)
Becton, Dickinson and Company (U.S.)
bioMérieux SA (France)
Danaher Corporation (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
QIAGEN N.V. (Netherlands)
Siemens Healthineers AG (Germany)
Thermo Fisher Scientific Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Illumina, Inc. (U.S.)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
Market Insights and Future Outlook
The report segments the Africa IVD market by offering (reagents & kits, instruments, and software & services), technology (including immunoassay, molecular diagnostics, and others), application (focusing on infectious diseases, diabetes, oncology, etc.), diagnostic approach (laboratory testing, point-of-care testing, and OTC/self-testing), and end user (diagnostic laboratories, hospitals, home healthcare, etc.).
Reagents & Kits Segment: Expected to register the highest CAGR of 3.3% during the forecast period, driven by the increasing incidence of infectious diseases and rising test volumes.
Immunoassay Technologies: Anticipated to dominate with a 34.5% market share in 2024, favored for their efficiency and accuracy in diagnosing prevalent diseases like HIV and malaria.
Infectious Diseases Application: Projected to hold the largest market share due to the high prevalence of diseases such as COVID-19 and malaria.
Quick Buy : https://www.meticulousresearch.com/Checkout/47708335
Geographical Insights
The report provides an extensive analysis of key markets, including South Africa, Nigeria, Egypt, and more. Notably, South Africa is expected to exhibit the highest growth rate of 8.3% during the forecast period, fueled by increasing healthcare investments and improved access to diagnostic services.
Key Questions Addressed in the Report
What is the current revenue generated by IVD products in Africa?
What growth rate is expected for IVD product demand over the next 5-7 years?
What are the major factors impacting the Africa IVD market?
Which segments are experiencing significant traction?
What are the key geographical trends and opportunities?
For a deeper dive into these insights and more, access the full report : https://www.meticulousresearch.com/request-sample-report/cp_id=5415
Contact Information
For more details, please contact:
Meticulous Research® Email: [email protected] Sales Contact: +1-646-781-8004 Connect with us on LinkedIn.
0 notes
Text
In Vitro Diagnostics Market Growth Trends and Strategies 2024 - 2030
The global in vitro diagnostics (IVD) market size was estimated at USD 77.92 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2030.
The growth can be attributed to increasing adoption of IVD owing to a rise in the incidence of infectious and chronic diseases. The development of automated IVD systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnoses is expected to fuel market growth. The rising number of IVD products being launched by key players is also fueling market growth. For instance, in November 2023, ARUP Laboratories received a CE mark from EU-IVDR for AAV5 DetectCDx, a companion diagnostic to select the eligibility of severe hemophilia A-affected patients for BioMarin’s new gene therapy, Roctavian.
Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high-impact rendering drivers of this market. Introduction of novel and highly accurate clinical laboratory tests is boosting the adoption of novel IVD tests worldwide. In June 2023, Toray Industries, Inc. received marketing approval from Japan’s Ministry of Health, Labour and Welfare for its Toray APOA2-iTQ used to diagnose pancreatic cancer. Moreover, in March 2023, Abbott received U.S. FDA clearance for its novel laboratory Traumatic Brain Injury (TBI) blood test in the U.S. Increasing approvals of IVD tests for life-threatening diseases are expected to create new opportunities in the untapped market.
Gather more insights about the market drivers, restrains and growth of the In Vitro Diagnostics Market
In Vitro Diagnostics Market Report Highlights
• Molecular diagnostics is anticipated to grow at the fastest CAGR from 2024 to 2030 owing to the rising adoption and usage rate
• Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs
• The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally
• North America dominated the global market in 2023 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure
Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.
• The global hepatitis diagnostic market size was valued at USD 3.82 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030.
• The global hematology diagnostics market size was valued at USD 7.54 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030.
In Vitro Diagnostics Market Segmentation
Grand View Research has segmented the global in vitro diagnostics (IVD) market report based on product, technology, application, end-use, test location, and region:
IVD Product Outlook (Revenue, USD Million, 2018 - 2030)
• Instruments
• Reagents
• Services
IVD Technology Outlook (Revenue, USD Million, 2018 - 2030)
• Immunoassay
o Instruments
o Reagents
o Services
• Hematology
o Instruments
o Reagents
o Services
• Clinical Chemistry
o Instruments
o Reagents
o Services
• Molecular Diagnostics
o Instruments
o Reagents
o Services
• Coagulation
o Instruments
o Reagents
o Services
• Microbiology
o Instruments
o Reagents
o Services
• Others
o Instruments
o Reagents
o Services
IVD Application Outlook (Revenue, USD Million, 2018 - 2030)
• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Diseases
• Drug Testing
• Others
IVD Test Location Outlook (Revenue, USD Million, 2018 - 2030)
• Point of Care
• Home-care
• Others
IVD End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Laboratory
• Home-care
• Others
IVD Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Spain
o Italy
o Russia
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o South Korea
o Australia
o Thailand
o Singapore
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait
Order a free sample PDF of the In Vitro Diagnostics Market Intelligence Study, published by Grand View Research.
#In Vitro Diagnostics Market#In Vitro Diagnostics Market size#In Vitro Diagnostics Market share#In Vitro Diagnostics Market analysis#In Vitro Diagnostics Industry
0 notes
Text
Coagulation Markers Market By Product Type, By Manufacturers, By End-User And Market Trend Analysis Forecast 2033
The Coagulation Markers Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Coagulation Markers Market: https://www.thebusinessresearchcompany.com/report/coagulation-markers-global-market-report
According to The Business Research Company’s Coagulation Markers Global Market Report 2024, The coagulation markers market size is expected to see strong growth in the next few years. It will grow to $1.52 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to a growing incidence of chronic diseases, rising adoption of personalized medicine, a growing global population, rising healthcare expenditures, and expansion in emerging markets. Major trends in the forecast period include the integration of AI and machine learning, the development of novel biomarkers, enhanced point-of-care technologies, automation in laboratories, wearable health technologies, telehealth and remote monitoring, and sustainable diagnostic practices.
The rise in the prevalence of blood disorders is expected to propel the growth of the coagulation markers market going forward. Blood disorders refer to a wide range of conditions that affect the blood's ability to function correctly. The prevalence of blood disorders is growing due to aging populations, increased awareness, and improved diagnostic capabilities. Coagulation markers help diagnose and manage blood disorders by assessing clotting function, identifying abnormalities, and monitoring treatment effectiveness for conditions like hemophilia and thrombosis. For instance, in May 2024, according to the Leukaemia Foundation, an Australia-based non-profit organization, currently around 135,000 people in Australia are living with a blood cancer or blood disorder, with this number projected to exceed 275,000 by 2035. Therefore, an increasing prevalence of blood disorders is driving the coagulation marker market.
Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=17117&type=smp
The coagulation markers market covered in this report is segmented –
1) By Product: D-Dimer Assay, Fibrinogen Assay 2) By Sample Type: Plasma, Whole Blood Sample, Other Sample Types 3) By Technology: Fluorescence Immunoassay, Enzyme-Linked Immuno Sorbent Assay (ELISA), Rapid Test, Particle Enhanced Immunoturbidimetric Assay 4) By Application: Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Trauma, Other Applications 5) By End User: Hospital, Specialty Clinics, Academic And Research Institute, Diagnostics Laboratories
Major companies operating in the coagulation markers market are focusing on developing technologically innovative solutions, such as automated blood coagulation analyzers, to improve diagnostic accuracy, enhance efficiency, and provide faster results for better patient management. An automated blood coagulation analyzer is a medical device that automatically performs various tests to evaluate blood clotting function, providing rapid and accurate results for diagnosing and managing coagulation disorders. For instance, in July 2021, Sysmex Corporation, a Japan-based provider of in-vitro diagnostic solutions, announced the launch of its new automated blood coagulation analyzers named CN-6000 and CS-5100, designed to provide efficient and accurate coagulation testing in clinical laboratories. The CN-6000 is a fully automated coagulation analyzer with a maximum throughput of 240 tests per hour, featuring automatic sample pre-treatment, clot detection, and quality control management. The CS-5100, on the other hand, is a compact and versatile coagulation analyzer suitable for small to medium-sized laboratories, offering a throughput of up to 120 tests per hour and a user-friendly interface. Both analyzers support a wide range of coagulation assays and are designed to streamline coagulation testing workflows, improve turnaround times, and enhance patient care in clinical laboratories.
The coagulation markers market report table of contents includes:
1. Executive Summary
2. Coagulation Markers Market Characteristics
3. Coagulation Markers Market Trends And Strategies
4. Coagulation Markers Market - Macro Economic Scenario
5. Global Coagulation Markers Market Size and Growth ............
32. Global Coagulation Markers Market Competitive Benchmarking
33. Global Coagulation Markers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Coagulation Markers Market
35. Coagulation Markers Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
0 notes
Text
0 notes
Text
In Vitro Diagnostics Market To Reach $101.58 Billion By 2030
The global in vitro diagnostics market size is expected to reach USD 101.58 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 4.4% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.
These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.
Request a free sample copy or view the report summary: In Vitro Diagnostics Market Report
In Vitro Diagnostics Market Report Highlights
Molecular diagnostics is anticipated to grow at the fastest CAGR from 2024 to 2030 owing to the rising adoption and usage rate
Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs
The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally
North America dominated the global market in 2023 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure
In Vitro Diagnostics Market Segmentation
Grand View Research has segmented the global in vitro diagnostics (IVD) market report based on product, technology, application, end-use, test location, and region:
IVD Product Outlook (Revenue, USD Million, 2018 - 2030)
Instruments
Reagents
Services
IVD Technology Outlook (Revenue, USD Million, 2018 - 2030)
Immunoassay
Instruments
Reagents
Services
Hematology
Instruments
Reagents
Services
Clinical Chemistry
Instruments
Reagents
Services
Molecular Diagnostics
Instruments
Reagents
Services
Coagulation
Instruments
Reagents
Services
Microbiology
Instruments
Reagents
Services
Others
Instruments
Reagents
Services
IVD Application Outlook (Revenue, USD Million, 2018 - 2030)
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing
Others
IVD Test Location Outlook (Revenue, USD Million, 2018 - 2030)
Point of Care
Home-care
Others
IVD End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Laboratory
Home-care
Others
IVD Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Russia
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Singapore
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of In Vitro Diagnostics (IVD) Market
Abbott
bioMérieux SA
QuidelOrtho Corporation
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Qiagen
Sysmex Corporation
Charles River Laboratories
Quest Diagnostics Incorporated
Agilent Technologies, Inc.
Danaher Corporation
BD
F. Hoffmann-La Roche Ltd.
0 notes
Text
Automated Blood Coagulation Analyzers Market Growth, Trend, and Prospects from 2023–2030
Automated Blood Coagulation Analyzers Market Growth,
The Automated Blood Coagulation Analyzers Market is expected to grow from USD 1.20 Billion in 2022 to USD 1.70 Billion by 2030, at a CAGR of 4.20% during the forecast period.
Get the Sample Report:https://www.reportprime.com/enquiry/sample-report/10612
Automated Blood Coagulation Analyzers Market Size
Automated Blood Coagulation Analyzers are medical devices used to diagnose and monitor blood clotting problems. The market research report identifies the market segment based on type, application, region, and market players. The type segment is further divided into fully automated and semi-automated devices. The application segment includes clinics, hospitals, research institutes, and others. The report covers the regions of North America, Asia Pacific, Middle East, Africa, Australia, and Europe. The major players mentioned in the report are Hycel, Tridema Engineering, Maccura Biotechnology Co, PZ Cormay, Wama Diagnostica, BPC BioSed, Caretium Medical Instruments, Grifols, HAEMONETICS, Roche, Medtronic, Instrumentation Laboratory, Technoclone, Rayto Life and Analytical Sciences, Accriva Diagnostics, URIT Medical Electronic, Helena Biosciences, Stago, ROBONIK, and Perlong Medical. The report also covers regulatory and legal factors specific to market conditions.
Automated Blood Coagulation Analyzers Market Key Players
Mazor Key Player is listed in the Automated Blood Coagulation Analyzers
Hycel
Tridema Engineering
Maccura Biotechnology Co
PZ Cormay
Wama Diagnostica
Buy Now & Get Exclusive Discount on this:https://www.reportprime.com/enquiry/request-discount/10612
Automated Blood Coagulation Analyzers Market Segment Analysis
The automated blood coagulation analyzers market is a rapidly growing and highly competitive segment of the clinical diagnostics industry. This market caters to the needs of hospitals, reference laboratories, and research institutions, which require reliable and efficient methods of measuring blood coagulation parameters. The market is expected to witness significant growth in the coming years due to several factors driving revenue growth.
One of the major factors contributing to the growth of the automated blood coagulation analyzers market is the increasing prevalence of chronic diseases such as cardiovascular diseases and cancer. The rising demand for accurate and timely diagnosis of blood coagulation disorders in these diseases is driving the adoption of advanced coagulation analyzers. In addition, the growing aging population and the increasing number of surgeries and trauma cases have also led to an increased demand for coagulation testing.
Another factor driving revenue growth is the increasing automation of laboratory processes. Automated blood coagulation analyzers are more efficient and have a higher level of accuracy compared to traditional manual methods. Additionally, the demand for point-of-care testing and decentralized testing is also on the rise, further driving the adoption of automated analyzers.
Some of the latest trends in the automated blood coagulation analyzers market include the integration of advanced technologies such as artificial intelligence and machine learning algorithms. This integration helps to improve the accuracy and efficiency of coagulation testing, enabling faster and more accurate diagnosis of blood coagulation disorders.
However, the market also faces some challenges, such as the high cost of automated blood coagulation analyzers, which may limit adoption in certain regions. Additionally, the lack of standardization in coagulation testing methods across different regions and laboratories can pose a challenge for the market.
The report’s main findings highlight the significant growth potential of the automated blood coagulation analyzers market in the coming years. The increasing prevalence of chronic diseases and the demand for more efficient and accurate laboratory processes are expected to drive revenue growth. In addition, the report recommends that companies focus on developing cost-effective analyzers that are easy to use and maintain, to expand market adoption.
In conclusion, the automated blood coagulation analyzers market is a highly competitive and growing segment of the clinical diagnostics industry. The market is being driven by factors such as the increasing prevalence of chronic diseases and the need for more efficient laboratory processes. The market also faces challenges such as the high cost of analyzers and the lack of standardization in testing methods. However, with the right strategies and product offerings, companies can successfully tap into this growing market.
This report covers impact on COVID-19 and Russia-Ukraine wars in detail.
Purchase This Report: https://www.reportprime.com/checkout?id=10612&price=3590
Automated Blood Coagulation Analyzers (by Application)
Clinics
Hospitals
Research Institutes
Others
Information is sourced from www.reportprime.com
0 notes
Text
Diagnostic Cartridge Field Diagnostic System Market Size, Growth with a CAGR of ~5% During 2023-2035 and Attain ~USD 12 Billion by 2035
Research Nester’s recent market research analysis on “Diagnostic Cartridge Field Diagnostic System Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitor’s analysis and a detailed overview of the global diagnostic cartridge field diagnostic system market in terms of market segmentation by type, end-user, and by region.
Increasing Importance of Point of Care Testing (POCT) to Promote Global Market Share of Diagnostic Cartridge Field Diagnostic System
The global diagnostic cartridge field diagnostic system market is estimated to grow majorly on account of the rising demand for point-of-care testing post-pandemic and amongst patients needing critical care. With the number of people with COVID-19 cases surging daily around the world, point-of-care testing (POCT) is gaining attention as a tool as it can be done rapidly and be performed by clinical personnel who are not trained in clinical laboratory sciences. Moreover, it enables more rapid, accurate, and timely clinical decision-making in the process of diagnosis, treatment choice, monitoring, and prognosis, as well as operational decision-making and resource utilization. Hence, with the growth in the utilization of POCT, the growth of the diagnostic cartridge field diagnostic system is also anticipated to prosper.
Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-3936
Some of the major growth factors and challenges that are associated with the growth of the global diagnostic cartridge field diagnostic system market are:
Growth Drivers:
Growing Prevalence of Chronic and Acute Diseases
Expanding Diagnostic Sector
Challenges:
The immensely slower penetration of the diagnostic cartridge field diagnostic system in developing countries, and the challenge of quality control and result reporting faced by the market due to lack of accuracy owing to test error are some of the major factors anticipated to hamper the global market size of diagnostic cartridge field diagnostic system.
Request for customization @ https://www.researchnester.com/customized-reports-3936
By type, the global diagnostic cartridge field diagnostic system market is segmented into infectious diseases testing, cardiac markers testing, coagulation testing, electrolytes testing, and others. The cardiac marker testing segment is to garner the highest revenue by the end of 2035 by growing at a significant CAGR over the forecast period. The rise in the number of people suffering from myocardial infarction (MI), commonly known as a heart attack is estimated to propel the segment growth. Cardiac marker tests can predict the symptoms of the condition as they can identify blood chemicals associated with myocardial infarction.
Further, the hospital sub-segment amongst the end-user is garnered a notable share over the forecast period owing to the rapid patient footfall in hospitals and the increasing demand for handheld/ portable diagnostics devices that are preferred to perform a test at a patient’s bedside.
Access Our Report at:
By region, the Asia Pacific diagnostic cartridge field diagnostic system market is to generate the highest revenue by the end of 2035. The flourishing medical tourism industry in countries like India together with the surge in collaborations of corporates and multi-national companies for the upliftment of the diagnostic market is anticipated to pool investment in the diagnostic cartridge field diagnostic system market.
The North American diagnostic cartridge field diagnostic system market is anticipated to register the highest shareholding owing to the rapid adoption of advanced medical technology in the region especially in the healthcare sector.
Finally, the market in Europe is projected to hold a majority of the share by the end of 2035 owing to the widespread of chronic lifestyle diseases such as diabetes amongst the aging population.
This report also provides the existing competitive scenario of some of the key players of the global diagnostic cartridge field diagnostic system market which includes company profiling of Siemens Healthineers AG, F. Hoffmann-La Roche AG, Danaher Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Arkray Inc., Becton, Dickinson and Company, Binx Health Limited, Nova Biomedical Corporation, Abbott Laboratories, and others.
About Us
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion, investment, etc. We believe every business can expand to its new horizon, provided the right guidance at the right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
#Diagnostic Cartridge Field Diagnostic System Market#Diagnostic Cartridge Field Diagnostic System#Diagnostic Cartridge Field Diagnostic System Market size
0 notes
Text
Analysis of Diagnostic Cartridge Field Diagnostic System Market to Grow with a CAGR of ~5% During 2023-2035 and Attain ~USD 12 Billion by 2035
New York – May 26, 2023 - Research Nester’s recent market research analysis on “Diagnostic Cartridge Field Diagnostic System Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitor’s analysis and a detailed overview of the global diagnostic cartridge field diagnostic system market in terms of market segmentation by type, end-user, and by region.
Increasing Importance of Point of Care Testing (POCT) to Promote Global Market Share of Diagnostic Cartridge Field Diagnostic System
The global diagnostic cartridge field diagnostic system market is estimated to grow majorly on account of the rising demand for point-of-care testing post-pandemic and amongst patients needing critical care. With the number of people with COVID-19 cases surging daily around the world, point-of-care testing (POCT) is gaining attention as a tool as it can be done rapidly and be performed by clinical personnel who are not trained in clinical laboratory sciences. Moreover, it enables more rapid, accurate, and timely clinical decision-making in the process of diagnosis, treatment choice, monitoring, and prognosis, as well as operational decision-making and resource utilization. Hence, with the growth in the utilization of POCT, the growth of the diagnostic cartridge field diagnostic system is also anticipated to prosper.
Some of the major growth factors and challenges that are associated with the growth of the global diagnostic cartridge field diagnostic system market are:
Growth Drivers:
Growing Prevalence of Chronic and Acute Diseases
Expanding Diagnostic Sector
Challenges:
The immensely slower penetration of the diagnostic cartridge field diagnostic system in developing countries, and the challenge of quality control and result reporting faced by the market due to lack of accuracy owing to test error are some of the major factors anticipated to hamper the global market size of diagnostic cartridge field diagnostic system.
Request Report Sample@
By type, the global diagnostic cartridge field diagnostic system market is segmented into infectious diseases testing, cardiac markers testing, coagulation testing, electrolytes testing, and others. The cardiac marker testing segment is to garner the highest revenue by the end of 2035 by growing at a significant CAGR over the forecast period. The rise in the number of people suffering from myocardial infarction (MI), commonly known as a heart attack is estimated to propel the segment growth. Cardiac marker tests can predict the symptoms of the condition as they can identify blood chemicals associated with myocardial infarction.
Further, the hospital sub-segment amongst the end-user is garnered a notable share over the forecast period owing to the rapid patient footfall in hospitals and the increasing demand for handheld/ portable diagnostics devices that are preferred to perform a test at a patient’s bedside.
By region, the Asia Pacific diagnostic cartridge field diagnostic system market is to generate the highest revenue by the end of 2035. The flourishing medical tourism industry in countries like India together with the surge in collaborations of corporates and multi-national companies for the upliftment of the diagnostic market is anticipated to pool investment in the diagnostic cartridge field diagnostic system market.
The North American diagnostic cartridge field diagnostic system market is anticipated to register the highest shareholding owing to the rapid adoption of advanced medical technology in the region especially in the healthcare sector.
Finally, the market in Europe is projected to hold a majority of the share by the end of 2035 owing to the widespread of chronic lifestyle diseases such as diabetes amongst the aging population.
This report also provides the existing competitive scenario of some of the key players of the global diagnostic cartridge field diagnostic system market which includes company profiling of Siemens Healthineers AG, F. Hoffmann-La Roche AG, Danaher Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Arkray Inc., Becton, Dickinson and Company, Binx Health Limited, Nova Biomedical Corporation, Abbott Laboratories, and others.
Request Report Sample@
0 notes
Text
0 notes
Text
EUROPE POINT-OF-CARE DIAGNOSTICS Market Growth, Industry Size-Share, Global Trends, Key Players Strategies and Upcoming Demand
Data Bridge Market Research analyses that the EUROPE POINT-OF-CARE DIAGNOSTICS MARKET will project a compound annual growth rate (CAGR) of 10.22% during the forecast period of 2022-2029.
A world class EUROPE POINT-OF-CARE DIAGNOSTICS MARKET research report is formulated with the finest and advanced tools of collecting, recording, estimating and analysing market data. With the systematic and comprehensive market research study, this market research report offers the facts associated with any subject in the field of marketing for Healthcare industry. It gives superior ideas and solutions in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behaviours. This EUROPE POINT-OF-CARE DIAGNOSTICS MARKET report has been prepared by considering several fragments of the present and upcoming market scenario.
EUROPE POINT-OF-CARE DIAGNOSTICS MARKET Scope and Market Size
The point-of-care diagnostics market is segmented on the basis of product, platform, prescription and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
On the basis of product, the point-of-care diagnostics market is segmented into glucose monitoring products, cardio metabolic, infectious disease, coagulation, pregnancy and fertility, tumor or cancer marker, urinalysis, cholesterol, haematology, drugs-of-abuse, fecal occult and others. Glucose monitoring products is further sub segmented into strips, meters and lancets and lancing device. Cardiometabolic is further sub segmented into cardiac marker, blood gas or electrolytes and HBA1C. Infectious disease is further sub segmented into influenza, HIV, hepatitis C, sexually transmitted disease (STD), healthcare-associated infection (HAI), respiratory infection, tropical disease and other infectious disease. Coagulation is further sub segmented into PT or INR and activated clotting time (ACT or APTT). Pregnancy and fertility is further sub segmented into pregnancy test and fertility test.
On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays.
On the basis of prescription, the point-of-care diagnostics market is segmented into prescription-based testing and OTC testing.
On the basis of end user, the point-of-care diagnostics market is segmented into clinical laboratories, outpatient healthcare and ambulatory care settings, hospitals or critical care centers, home care, research laboratories and other.
Get the Free sample copy of the report here:
Some of the key questions answered in this report:
How has the EUROPE POINT-OF-CARE DIAGNOSTICS MARKET performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the EUROPE POINT-OF-CARE DIAGNOSTICS MARKET?
What are the key regional markets?
What are the key driving factors and challenges in the industry?
What is the structure of the EUROPE POINT-OF-CARE DIAGNOSTICS MARKET and who are the key players?
Market Analysis and Insights: EUROPE POINT-OF-CARE DIAGNOSTICS MARKET
The point-of-care diagnostics market is expected to witness market growth at a rate of 10.22% in the forecast period of 2022 to 2029. Data Bridge Market Research report on point-of-care diagnostics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the incidence of target diseases is escalating the growth of point-of-care diagnostics market.
Point-Of-Care diagnostics are the approaches that are utilized to identify infections early and quickly. Such procedures are extremely sensitive, cost-efficient and produce results within a short timeframe. These testing methods are utilized by schools, physicians, outpatients, clinical labs and home health.
Major factors that are expected to boost the growth of the point-of-care diagnostics market in the forecast period are the rise in the need for home healthcare has pushed the manufacturers. Furthermore, the growing importance of point-of-care diagnostics in the environmental monitoring and public health is further anticipated to propel the growth of the point-of-care diagnostics market. Moreover, the technological developments and new product releases is further estimated to cushion the growth of the point-of-care diagnostics market. On the other hand, the expenses pressure because of repayment cuts and budget restriction is further projected to impede the growth of the point-of-care diagnostics market in the timeline period.
EUROPE POINT-OF-CARE DIAGNOSTICS MARKET - Regional Level Analysis
The countries covered in the point-of-care diagnostics market report are the Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
EUROPE POINT-OF-CARE DIAGNOSTICS MARKET - Share Analysis:
The North America point-of-care diagnostics market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the point-of-care diagnostics market.
Key player - EUROPE POINT-OF-CARE DIAGNOSTICS MARKET
Some of the major players operating in the EUROPE POINT-OF-CARE DIAGNOSTICS MARKET are Abbott, Danaher, BD, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Instrumentation Laboratory S.p.A. – Werfen, bioMérieux SA, Trividia Health, Inc., QIAGEN, Sekisui Diagnostics, Siemens Healthcare GmbH, Quidel Corporation, Spectral Medical Inc., Abaxis, Nova Biomedical, Trinity Biotech, Alfa Scientific Designs, Inc., ?PTS Diagnostics, Bio-Rad Laboratories, Inc., and Medica Corporation among others.
Get Full Access of Report@
https://www.databridgemarketresearch.com/reports/europe-point-of-care-diagnostics-market
MAJOR TOC OF THE REPORT
Chapter One: Introduction
Chapter Two: Scope and Market Size
Chapter Three: Analysis and Insights
Chapter Four: Country Level Analysis
Chapter Five: Share Analysis
Chapter Six: Key player
Get TOC Details:
https://www.databridgemarketresearch.com/toc/?dbmr=europe-point-of-care-diagnostics-market Top Trending Reports:
Global Autoclave Market
Global Proctoscope Market
Global Molecular Methods Market
Global Wound Debridement Market
Global Human Papilloma Virus Testing Market
Global Non-Small Cell Lung Cancer Market
Global CPAP Market
Global RNA Markers Market
Global Healthcare Cloud Computing Market
Global Medical Image Management Market
Global Pharmacogenetic Testing Market
Global Hemodialysis Services Market
Global Hemostatic Wound Dressing Market
Global Interventional Radiology Products Market
Global Lab Accessories Market
Global Label-free Array Systems Market
Global Laboratory Gas Generators Market
Global Life Science Analytics Market
Global Mediastinoscopes Market
Global Medical Alert System Market
Global EDS, WDS, EBSD, Micro-XRF Instruments Market
Global Direct-to-Consumer (DTC) Genetic Testing Market
Global Q- Polymerase Chain Reaction and D- Polymerase Chain Reaction Devices Market
Asia-Pacific (APAC) Q-PCR and D-PCR Devices Market
Europe Q-PCR and D-PCR Devices Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-386.8-2818
Email: [email protected]
0 notes
Text
Meticulous Research® Unveils Comprehensive Analysis of the Africa IVD Market Forecasting Growth to $1.65 Billion by 2031
Meticulous Research®, a premier global market research firm, has released its latest report titled, “Africa IVD Market Size, Share, Forecast & Trends Analysis by Offering, Technology (Immunoassay, PoC, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoCT), End User - Forecast to 2031.”
The report projects that the Africa in vitro diagnostics (IVD) market will reach $1.65 billion by 2031, growing at a CAGR of 3.1% from 2024 to 2031. This growth is driven by several factors, including:
Increasing prevalence of chronic and infectious diseases.
Significant investments from IVD market players in Africa.
Rising demand for Point-of-Care (POC) and rapid diagnostic solutions.
Growing geriatric population.
Government initiatives enhancing healthcare infrastructure.
Increased healthcare expenditure and R&D investments.
Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5415
Despite these opportunities, the market faces challenges such as high costs associated with advanced IVD products, variability in rapid test results, and stringent regulatory requirements for high and moderate-complexity tests.
Emerging Opportunities
The report highlights the growing awareness of early diagnosis, advancements in genomics and proteomics, and the rising adoption of personalized medicine as potential growth drivers for market stakeholders. However, uneven healthcare access and a shortage of trained professionals remain significant hurdles.
Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/africa-ivd-market-5415
Key Players in the Africa IVD Market
Leading companies in the Africa IVD market include:
Abbott Laboratories (U.S.)
Becton, Dickinson and Company (U.S.)
bioMérieux SA (France)
Danaher Corporation (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
QIAGEN N.V. (Netherlands)
Siemens Healthineers AG (Germany)
Thermo Fisher Scientific Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Illumina, Inc. (U.S.)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
Market Insights and Future Outlook
The report segments the Africa IVD market by offering (reagents & kits, instruments, and software & services), technology (including immunoassay, molecular diagnostics, and others), application (focusing on infectious diseases, diabetes, oncology, etc.), diagnostic approach (laboratory testing, point-of-care testing, and OTC/self-testing), and end user (diagnostic laboratories, hospitals, home healthcare, etc.).
Reagents & Kits Segment: Expected to register the highest CAGR of 3.3% during the forecast period, driven by the increasing incidence of infectious diseases and rising test volumes.
Immunoassay Technologies: Anticipated to dominate with a 34.5% market share in 2024, favored for their efficiency and accuracy in diagnosing prevalent diseases like HIV and malaria.
Infectious Diseases Application: Projected to hold the largest market share due to the high prevalence of diseases such as COVID-19 and malaria.
Quick Buy : https://www.meticulousresearch.com/Checkout/47708335
Geographical Insights
The report provides an extensive analysis of key markets, including South Africa, Nigeria, Egypt, and more. Notably, South Africa is expected to exhibit the highest growth rate of 8.3% during the forecast period, fueled by increasing healthcare investments and improved access to diagnostic services.
Key Questions Addressed in the Report
What is the current revenue generated by IVD products in Africa?
What growth rate is expected for IVD product demand over the next 5-7 years?
What are the major factors impacting the Africa IVD market?
Which segments are experiencing significant traction?
What are the key geographical trends and opportunities?
For a deeper dive into these insights and more, access the full report : https://www.meticulousresearch.com/request-sample-report/cp_id=5415
Contact Information
For more details, please contact:
Meticulous Research® Email: [email protected] Sales Contact: +1-646-781-8004 Connect with us on LinkedIn.
0 notes
Text
0 notes
Text
In Vitro Diagnostics Quality Control Market Research Report and Industry Analysis By 2026
The global IVD quality control market size is expected to reach USD 1.24 billion by 2026, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 4.1% over the forecast period. Continually evolving technology-oriented changes in the diagnostics field and growing need to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and Point-of-Care (PoC) devices. Patients rely on self-testing IVD devices for long-term disease management and hence it is important for such devices to be checked, in terms of result reproducibility and validity, to guarantee patient safety.
Rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the market. In addition to quality assessments, amendments to the regulatory framework are made intermittently to enhance the existing standards with the main objective of safeguarding qualitative superiority of the diagnostic services. In May 2016, the European Union passed an agreement to update the pre-existing regulations pertaining to IVD devices, wherein the updates were in concern with raising the patient safety levels, particularly for disabled persons. The presence of third-party agencies for independent assessment of the IVD devices is expected to elevate the current safety standards, which will drive the In Vitro Diagnostics (IVD) Quality Control market further.
Further key findings from the study suggest:
• In 2018, the clinical chemistry was the second-largest application segment of the global IVD market, in terms of market share
• Demand for preventive medicine and rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for the segment’s growth
• Molecular diagnostics is projected to be the fastest-growing segment due to increasing technical complexity of molecular diagnostic testing and need for quality evaluation to ensure standards
• These tests are of prime importance as the outcomes enable healthcare practitioners make critical treatment decisions
• Hospitals was the largest segment in 2018 due to the presence of advanced technology-based devices like Next Generation Sequencing (NGS) and microarrays, and rising applications of the optimized quality-control procedures
• North America was the dominant regional market in 2018 due to the presence of over 150,000 registered diagnostics labs and is likely to maintain the dominance throughout the forecast years
• Siemens Healthcare GmbH; Roche Diagnostics; Alere, Inc.; Abbott Laboratories, Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Quidel Corp.; Becton, Dickinson and Company; bioMerieux, Inc.; Sysmex Corp.; Sero AS; and Thermo Fisher Scientific, Inc. are some of the key companies in the global market
The global In Vitro Diagnostics (IVD) and IVD quality control market combines to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period.
In Vitro Diagnostics Quality Control Market Segmentation:
Grand View Research has segmented the global IVD quality control market on the basis of application, type, end use, and region:
IVD Quality Control Application Outlook (Revenue, USD Million, 2014 – 2026)
• Immunochemistry
• Hematology
• Clinical Chemistry
• Molecular Diagnostics
• Coagulation
• Microbiology
• Others
IVD Quality Control Type Outlook (Revenue, USD Million, 2014 – 2026)
• Quality Control
Quality Controls, by Type
Plasma-based Control
Serum-based Control
Whole Blood-based Control
Others
Quality Controls, by Application
Immunochemistry
Hematology
Clinical Chemistry
Molecular Diagnostics
Coagulation
Microbiology
Others
• Quality Assurance Services
Immunochemistry
Hematology
Clinical Chemistry
Molecular Diagnostics
Coagulation
Microbiology
Others
• Data Management
Clinical Chemistry
Immunochemistry
Hematology
Molecular Diagnostics
Coagulation
Microbiology
Others
IVD Quality Control End Use Outlook (Revenue, USD Million, 2014 – 2026)
• Hospitals
• Laboratories
• Home-care
• Others
IVD Quality Control Regional Outlook (Revenue, USD Million, 2014 – 2026)
• North America
U.S.
Canada
• Europe
U.K.
Germany
France
Spain
Italy
Russia
• Asia Pacific
Japan
China
India
South Korea
Singapore
Australia
• Latin America
Brazil
Argentina
• Middle East & Africa
South Africa
UAE
Saudi Arabia
Order a free sample of this Intelligence study @ https://www.grandviewresearch.com/sector-report/in-vitro-diagnostics-ivd-quality-control-industry-data-book/request/rs1
#In Vitro Diagnostics Quality Control Market#In Vitro Diagnostics Quality Control Market Research#In Vitro Diagnostics Quality Control Market Report#In Vitro Diagnostics Quality Control Market analysis#In Vitro Diagnostics Quality Control Industry
0 notes
Link
#Point-of-Care Coagulation Testing Market#Point-of-Care Coagulation Testing Market Share#Point-of-Care Coagulation Testing Market Size#Point-of-Care Coagulation Testing Market Trends
0 notes
Link
0 notes
Link
POC coagulation testing involves the use of devices and instruments for monitoring coagulation at hospitals, clinics, or at patient homes. Measurements of coagulation are important to diagnose blood clotting disorders.
#Point-of-Care Coagulation Testing#Point-of-Care Coagulation Testing Market#Point-of-Care Coagulation Testing Market Size
0 notes